Pfizer’s 2021 profits doubled to $22 billion on strong Covid-19 vaccine sales
NEW DELHI: Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual...
NEW DELHI: Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual...
NEW DELHI: Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can...
NEW DELHI: The anti-COVID-19 vaccines by US pharma majors Pfizer and Johnson & Johnson (J&J) that are being used in...
NEW DELHI: A single dose of Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection from...
LONDON: The Delta variant of coronavirus, first identified in India, doubles the risk of hospitalisation compared with the Alpha variant...
NEW DELHI: President Joe Biden plans to announce on Thursday that the US will purchase and donate half a billion...
NEW DELHI: Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine...
NEW DELHI: Global pharma major Pfizer is sending its medicines worth USD 70 million (over Rs 510 crore), from its...
NEW DELHI: Pfizer said that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies...
US pharmaceuticals giant Pfizer is planning a new version of its coronavirus vaccine that can be stored in a standard...